Investment Partners Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$522K Buy
4,062
+11
+0.3% +$1.29K 0.29% 95
2026
Q1
$487K Buy
4,051
+4
+0.1% +$462 0.3% 93
2025
Q4
$426K Buy
4,047
+5
+0.1% +$469 0.27% 102
2025
Q3
$339K Sell
4,042
-2,580
-39% -$213K 0.22% 123
2025
Q2
$524K Sell
6,622
-22
-0.3% -$1.75K 0.36% 83
2025
Q1
$596K Sell
6,644
-5,154
-44% -$481K 0.47% 70
2024
Q4
$1.17M Buy
11,798
+716
+6% +$73.8K 0.92% 28
2024
Q3
$1.26M Buy
11,082
+6
+0.1% +$713 1.03% 27
2024
Q2
$1.37M Sell
11,076
-150
-1% -$19.3K 1.22% 21
2024
Q1
$1.48M Sell
11,226
-446
-4% -$55K 1.34% 18
2023
Q4
$1.27M Buy
+11,672
New +$1.21M 1.27% 23

Other funds holding MRK

Investment Partners Asset Management's MRK Position: Q2 2026 in Review

Investment Partners Asset Management increased its Merck (MRK) stake by 0.27% in Q2 2026, buying an estimated $1.29K and bringing the position to 4,062 shares worth $522K. The position accounts for 0.29% of the portfolio, ranked #95.

Investment Partners Asset Management first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.48M in Q1 2024. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Investment Partners Asset Management held 4,062 shares of Merck worth $522K as of Q2 2026.
  • Investment Partners Asset Management bought 11 Merck shares in Q2 2026, an estimated $1.29K.
  • Merck made up 0.29% of Investment Partners Asset Management's portfolio in Q2 2026, its #95 holding.
  • Investment Partners Asset Management first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • Investment Partners Asset Management's Merck position peaked at $1.48M in Q1 2024.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Investment Partners Asset Management's 13F filing for Q2 2026, filed 24 Jul 2026.